All News #Library
Biotech
Lilly Signs $1.3 B Deal with Superluminal for Obesity Medicines
15 Aug 2025 //
REUTERS
Superluminal’s MC4R Agonist Advances for Treatment of Obesity
22 Jul 2025 //
PR NEWSWIRE
Axcelead, Superluminal to Collaborate on Drug Discovery
23 Jun 2025 //
BUSINESSWIRE
Superluminal Medicines Closes $120 Million Series A Round
09 Sep 2024 //
GLOBENEWSWIRE

Market Place
Sourcing Support